Dose-ranging Study of SKF7™ for Obesity

PHASE2CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

May 20, 2021

Study Completion Date

May 22, 2021

Conditions

Obesity

Interventions

DRUG

low-dose

Dosage 1

DRUG

Middle-dose

Dosage 2

DRUG

Higher-dose

Dosage 3

DRUG

Placebo

Trial Locations (3)

Indonesia Medical Education and Research Institute, Jakarta

Faculty of Medicine, Krida Wacana Christian University, Jakarta

Makara Satellite Clinic, Depok

All Listed Sponsors

collaborator

Medika Natura Sdn Bhd

INDUSTRY

lead

Indonesia University

OTHER

NCT04557267 - Dose-ranging Study of SKF7™ for Obesity | Biotech Hunter | Biotech Hunter